A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)
Clinical trial NCT04852705 · UNKNOWN
Trial details
- NCT number
- NCT04852705
- Sponsor
- Shenzhen Kangtai Biological Products Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2021-11-01
- Enrollment
- 28000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.